News Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Market Closed - Deutsche Boerse AG Other stock markets 07:39:52 2024-04-26 am EDT			5-day change	1st Jan Change
2.179 ^EUR	+0.09%		+7.60%	+4.21%

Mar. 19	Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	CI
Mar. 06	Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oramed Pharmaceuticals : 13D-Nadav Kidron	Mar. 26	PU
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	Mar. 19	PU
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	Mar. 19	CI
Oramed Pharmaceuticals : Other Report or Announcement	Mar. 18	PU
Oramed Pharmaceuticals : Other Report or Announcement	Mar. 18	PU
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	Jan. 19	CI
Oramed Pharmaceuticals : Other Report or Announcement	Jan. 02	PU
Oramed Pharmaceuticals : Other Report or Announcement	Dec. 24	PU
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	Dec. 19	CI
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	Dec. 19	PU
Oramed: Q3 Earnings Snapshot	Nov. 10	AQ
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Oramed Pharmaceuticals Inc.(TASE:ORMP) dropped from TA-125 Index	Nov. 03	CI
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	23-09-21	MT
Scilex Holding Company announced that it has received $101.875 million in funding from Oramed Pharmaceuticals Inc.	23-09-20	CI
Oramed Pharmaceuticals Inc. cancelled the acquisition of 40.17% stake in Scilex Holding Company from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q).	23-09-20	CI
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Oramed Pharmaceuticals : Other Report or Announcement	23-08-07	PU
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K	23-08-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Equities

OJU1

US68403P2039

Summary

Filters